Clinical Trial Update: Sympathetic Nerve Activity in Renal Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial examining sympathetic nerve activity in chronic kidney disease with hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Chronic Kidney Disease, Hypertension | Phase 4 | Status: WITHDRAWN